Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Intangibles (2017 - 2025)

Historic Intangibles for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $22.8 billion.

  • Takeda Pharmaceutical's Intangibles fell 1213.74% to $22.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $22.8 billion, marking a year-over-year decrease of 1213.74%. This contributed to the annual value of $23.8 billion for FY2025, which is 1956.91% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Intangibles of $22.8 billion as of Q4 2025, which was down 1213.74% from $22.4 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Intangibles registered a high of $36.9 billion during Q1 2021, and its lowest value of $22.4 billion during Q3 2025.
  • In the last 5 years, Takeda Pharmaceutical's Intangibles had a median value of $29.6 billion in 2024 and averaged $29.3 billion.
  • Its Intangibles has fluctuated over the past 5 years, first skyrocketed by 1890849.81% in 2021, then crashed by 2009.37% in 2022.
  • Over the past 5 years, Takeda Pharmaceutical's Intangibles (Quarter) stood at $33.4 billion in 2021, then decreased by 20.09% to $26.7 billion in 2022, then rose by 3.98% to $27.7 billion in 2023, then dropped by 6.21% to $26.0 billion in 2024, then fell by 12.14% to $22.8 billion in 2025.
  • Its last three reported values are $22.8 billion in Q4 2025, $22.4 billion for Q3 2025, and $23.7 billion during Q2 2025.